Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22)

被引:0
|
作者
Hirai, H [1 ]
Ogawa, S [1 ]
Kurokawa, M [1 ]
Yazaki, Y [1 ]
Mitani, K [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 113, Japan
来源
GENES CHROMOSOMES & CANCER | 1999年 / 26卷 / 01期
关键词
D O I
10.1002/(SICI)1098-2264(199909)26:1<92::AID-GCC13>3.0.CO;2-U
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The t(3;21)(q26;q22) is a recurring chromosomal abnormality in blastic crisis of chronic myelogenous leukemia (CML) and in therapy-related myelodysplastic syndrome and acute leukemia. In order to clarify the genetic recombination mechanism underlying the t(3;21), we molecularly cloned the breakpoints and determined their nucleotide sequence in a case of CML in blastic crisis with t(3;21). Near the breakpoint on chromosome 21, three homopyrimidine (CT)-rich sequences were found. We also identified a sequence homologous to the topoisomerase II binding and cleavage consensus sequence surrounding the breakpoint on chromosome 3, and two topoisomerase II binding and cleavage consensus sequences near the breakpoint on chromosome 21. In addition, around the breakpoint on chromosome 21, four chi-like sequences, potential consensus signals for activating recombination, were found. There were no Alu sequences or antigen receptor gene-like heptamer/nonamer signal sequences within the breakpoints on chromosomes 3 and 21. The breakpoints were found adjacent to the topoisomerase II binding and cleavage consensus sequence or the homopyrimidine-rich sequence. Furthermore, the chi-like sequences and the homopyrimidine-rich sequence were detected on chromosome 21 but not on chromosome 3. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 50 条
  • [21] B Lymphoblastic Leukemia (ALL) Associated with Inv(3) (q21q26)/t(3;3)(q21;q26)
    Hoehn, D.
    Chen, S. S.
    Lennon, P. A.
    Medeiros, L. J.
    Lin, P.
    LABORATORY INVESTIGATION, 2011, 91 : 301A - 301A
  • [22] B Lymphoblastic Leukemia (ALL) Associated with Inv(3) (q21q26)/t(3;3)(q21;q26)
    Hoehn, D.
    Chen, S. S.
    Lennon, P. A.
    Medeiros, L. J.
    Lin, P.
    MODERN PATHOLOGY, 2011, 24 : 301A - 301A
  • [23] A case of myelodysplastic syndrome with t(10;18)(q26;q21)
    Ohba, Yusuke
    Yamada-Fujiwara, Minami
    Minagawa, Tadanori
    Watanabe, Suguru
    Okitsu, Yoko
    Izumi, Yoshihiko
    Kameoka, Junichi
    Takahashi, Shinichiro
    JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (04) : 382 - 384
  • [24] FISH analysis of masked translocation of t(8;21)(q22;q22)
    Harrison, C
    Ross, F
    RadfordWeiss, I
    LeGuyader, G
    Rack, K
    Macintyre, E
    Vekemans, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1243 - 1243
  • [25] AML1 activation through t(3;21)(q26;q22): An aggressive syndrome of myeloid blast transformation following antimetabolite therapy
    Yin, CC
    Cortes, J
    Glassman, AB
    Valbuena, JR
    Hayes, K
    Kantarjian, H
    Jones, D
    LABORATORY INVESTIGATION, 2005, 85 : 259A - 259A
  • [26] Aleukaemic acute myeloid leukaemia with t(8;21)(q22;q22)
    Wong, K. F.
    Siu, Lisa L. P.
    Wong, W. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (04) : 345 - 345
  • [27] Molecular and Clinical Aspects of Acute Myeloid Leukemia with Inv(3)(q21q26)/t(3;3)(q21;q26) Carrying Spliceosomal Mutations
    Awada, Hassan
    Kerr, Cassandra M.
    Rogers, Heesun J.
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD, 2020, 136
  • [28] Duplication of der(21) t(8;21)(q22;q22) in Acute Myeloid Leukemia
    Yamamoto, Katsuya
    Okamura, Atsuo
    Matsuoka, Hiroshi
    Minami, Hironobu
    INTERNAL MEDICINE, 2014, 53 (01) : 73 - 74
  • [29] AML1 activation through t(3;21)(q26;q22): An aggressive syndrome of myeloid blast transformation following anti metabolite therapy
    Yin, CC
    Cortes, J
    Glassman, AB
    Valbuena, JR
    Hayes, K
    Kantarjian, H
    Jones, D
    MODERN PATHOLOGY, 2005, 18 : 259A - 259A
  • [30] 46,XX,t(5;15)(q22;q26)伴反复流产一例
    丁明
    焦云萍
    中华医学遗传学杂志, 1998, (02) : 49 - 49